Solid oral dosage form of valopi citabine (val-mCyd) and method of preparing it

Details for Australian Patent Application No. 2006226521 (hide)

Owner Novartis AG

Inventors Meyer, Andreas; Jores, Katja

Agent Davies Collison Cave

Pub. Number AU-A-2006226521

PCT Pub. Number WO2006/100087

Priority 60/664,733 24.03.05 US

Filing date 23 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/7052 (2006.01)

C07H 19/067 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100087 Priority application(s): WO2006/100087

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226522-Neural stem cells

2006226517-Use of detergent additives for reducing a particle amount in the exhaust gas of direct injection diesel engines